Enlivex Therapeutics Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$29,068,000 over the previous period. Total operating expenses were $29,395,000.
Profit Margin
| 2014 | 0 | -7.02M | |
|---|---|---|---|
| 2015 | 0 | -15.36M | |
| 2016 | 0 | -16.02M | |
| 2017 | 0 | -5.94M | |
| 2018 | 0 | -4.24M | |
| 2019 | 0 | -10.14M | |
| 2020 | 2.27M | -13.86M | -608.83% |
| 2021 | 0 | -9.64M | |
| 2022 | 0 | -42.40M | |
| 2023 | 0 | -29.06M |
ENLV Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 2.27M | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 835K | 777K | 546K | 286K | 297K | 121K | 12K | 25K | 17K | 0 |
Gross profit | -835K | -777K | -546K | 1.99M | -297K | -121K | -12K | -25K | -17K | 0 |
Operating exp. | ||||||||||
Research and development | 19.23M | 18.69M | 12.88M | 6.08M | 5.72M | 4.25M | 2.51M | 8.88M | 7.69M | 4.44M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 479K | 0 | 829K | 0 |
Total operating expenses | 29.39M | 25.79M | 19.28M | 9.78M | 8.61M | 5.29M | 5.95M | 15.86M | 15.47M | 7.08M |
Operating income | -29.39M | -25.79M | -19.28M | -9.78M | -8.61M | -5.29M | -5.95M | -15.86M | -15.47M | -7.08M |
Other income (expenses), net | 327K | -5.26M | 4.82M | -2.03M | -765K | 922K | -67K | 60K | 135K | 58K |
Income before tax | -29.06M | -31.06M | -14.46M | -11.82M | -9.38M | -4.24M | -5.91M | -15.80M | -15.34M | -7.02M |
Income tax expense | 0 | 11.34M | -4.82M | 2.03M | 765K | 1.05M | 28K | 216K | 24K | 0 |
Net income | -29.06M | -42.40M | -9.64M | -13.86M | -10.14M | -4.24M | -5.94M | -16.02M | -15.36M | -7.02M |
Earnings per share | ||||||||||
Basic EPS | -1.56 | -2.31 | -0.54 | -1.05 | -1.17 | -1.21 | -14.35 | -40.29 | -43.19 | -22.91 |
Diluted EPS | -1.56 | -2.31 | -0.54 | -1.05 | -1.17 | -1.21 | -13.88 | -40.29 | -43.19 | -22.91 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |